Microba Life Sciences Ltd
ASX:MAP
Microba Life Sciences Ltd
Cost of Revenue
Microba Life Sciences Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
M
|
Microba Life Sciences Ltd
ASX:MAP
|
Cost of Revenue
-AU$2.7m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Sonic Healthcare Ltd
ASX:SHL
|
Cost of Revenue
-AU$1.3B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Cost of Revenue
-AU$21.8m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
Capitol Health Ltd
ASX:CAJ
|
Cost of Revenue
-AU$16.2m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-17%
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Cost of Revenue
-AU$126.1m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
H
|
Healius Ltd
ASX:HLS
|
Cost of Revenue
-AU$218.7m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-5%
|
See Also
What is Microba Life Sciences Ltd's Cost of Revenue?
Cost of Revenue
-2.7m
AUD
Based on the financial report for Jun 30, 2023, Microba Life Sciences Ltd's Cost of Revenue amounts to -2.7m AUD.
What is Microba Life Sciences Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 3Y
-23%
Over the last year, the Cost of Revenue growth was -18%. The average annual Cost of Revenue growth rates for Microba Life Sciences Ltd have been -23% over the past three years .